Oriflame Unveils Breakthrough Research on Oripeptide-3 and Skin Longevity
Mumbai: Oriflame has announced new scientific findings on Oripeptide-3, its patented bioactivating technology and the core of the NovAge+ skincare range, revealing its direct support for five key biological drivers of skin ageing. The discovery marks a significant advancement in the company’s long-term research into skin longevity, cellular health, and ageing well.
Two Decades of Research
Developed over nearly twenty years, Oripeptide-3 is designed to work with the skin’s natural biology to extend its health and functional lifespan. The latest research highlights its positive impact on core skin longevity markers, laying the foundation for healthier, more resilient, and youthful-looking skin.
Five Hallmarks of Ageing
Oripeptide-3 addresses five recognised hallmarks of ageing by:
- Reactivating aged cells and improving overall skin function
- Helping protect DNA integrity to enhance firmness and elasticity
- Maintaining protein quality to reduce oxidative stress and boost radiance
- Supporting natural cellular renewal for improved clarity and vitality
- Boosting cellular energy for repair, renewal, and daily defence
Expert Insights
“Longevity is rightly the next frontier in beauty and we are proud to be leading this transformation with our skin longevity research at the molecular and cellular level,” said Lene Visdal-Johnsen, PhD, Director, Scientific Research and Innovation, Oriflame Global R&D.
“As consumers increasingly look for solutions that work deeper and deliver long-term skin benefits, innovations like Oripeptide-3 reflect our focus on advanced research and future-ready skincare,” added Edyta Kurek, Senior Vice President & Head, Oriflame India and Indonesia.
Commitment to Innovation
With these findings, Oriflame reinforces its position in advanced skin biology and reaffirms its commitment to innovation that supports long-term skin health and performance.
